New imaging method peers inside breast tumors without surgery
NCT ID NCT02284919
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 13 times
Summary
This study tests a new imaging method using a radioactive tracer called [18F]ISO-1 to measure sigma-2 receptors in breast cancer. These receptors are linked to how fast cancer cells multiply. About 30 adults with known or suspected breast cancer will receive a PET/CT scan to see if the tracer's uptake matches lab tests of cell growth. The goal is to gather knowledge, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania Hospital
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.